Rising ACA Costs Leave Many Unable To Pay for Coverage
via HealthDayTHURSDAY, April 16, 2026 — Higher health insurance costs are forcing some people to walk away from coverage even after signing up.
About 14% of people who enrolled in Affordable Care Act (ACA) plans for 2026 did not pay their first monthly premium, according to a new analysis from Wakely Consulting Group, an actuarial firm.
That’s much higher than the usual early-year drop-off, which is typically in the mid-single digits.
“It’s a big drop,” Michelle Anderson, a consulting actuary at Wakely, told The Wall Street Journal.
It likely owes to premium hikes following expiration of expanded federal subsidies introduced during the pandemic.
Enrollment was already slipping, falling to 23 million in 2026 from more than 24 million last year. Millions more could lose coverage if they don’t make payments within a three-month grace period, The Wall Street Journal reported.
Some patients say the cost increases left them with limited options.
Sarah Smith, a 53-year-old office manager in Ohio, said her monthly premium jumped from about $150 last year to roughly $700 after losing her subsidy. Her ACA policy also covered her 20-year-old son.
She decided to buy a cheaper short-term policy instead, even though it offers less protection.
“I try not to think about it,” Smith told The Wall Street Journal. “Knock on wood, hope that he’s OK, I’m OK," she said, referring to herself and her now uninsured son.
Others are going without insurance entirely. Sharon Dunham, a 63-year-old cancer survivor, said her monthly premium would have risen to about $980, up from $614 last year.
"It is definitely terrifying," she told The Wall Street Journal. “There’s the very real possibility that I can’t do anything if it shows up.”
Experts say rising costs can change who stays insured. Younger, more healthier people are more likely to drop coverage.
Wakely’s data showed that people who paid their initial premiums in 2026 were about 10% less healthy, based on their expected medical costs, than those who did not pay at all.
That shift could lead to higher premiums in the future, as insurers raise prices to cover increased costs.
The impact varies by state. Some states saw higher rates of people not paying, especially those using HealthCare.gov.
In Arizona, Blue Cross Blue Shield reported losing more than 30% of its ACA enrollees for 2026 due to non payments, compared with 2% last year.
“It is simply because the cost of health insurance is more than what they can afford,” CEO Pam Kehaly said.
Wakely estimates that ACA enrollment could drop by 17% to 26% this year compared to 2025.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-17 02:06
Read more
- ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy 1 mg (epinephrine nasal spray) Label
- Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
- Nerve Stimulation Therapy May Ease Fibromyalgia Pain, Fatigue
- Odds of Mental, Physical Health Outcomes Elevated for Children With TBI
- Low-Cost Platform Capable of Automated Anterior Segment Imaging for Eye Disease Screening
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions